The $15bn ‘viral’ AI start-up changing how American doctors treat patients

OpenEvidence has reached a $15 billion valuation as its AI-driven platform transforms how American doctors treat patients. The founder reports that two-thirds of US physicians currently utilize the ad-powered chatbot tool. While the technology aims to significantly enhance treatment efficiency and diagnostic accuracy, its widespread adoption has prompted an ongoing debate regarding patient care. This viral AI start-up represents a major shift in healthcare, leveraging artificial intelligence to reshape clinical workflows and medical decision-making processes.